NSE ScannerOpen the scanner

Chemicals · Chemicals: Specialty · NSE: NOCIL · data 2026-11-01

NOCIL Limited

₹137.12-5.66% on 30 OctHealth: Weak 3/10
Feb 2026Low ₹129.93 · High ₹206.3-4.8%

In plain words

Price: 35.1% below its 52-week high of ₹211.2.

Delivery: 52.3% of traded shares were kept for delivery over the last 10 sessions, against 46.4% over the last 60.

Latest results: a net profit of ₹24 cr for the quarter ended Sept 2026 (+98.4% on the same quarter a year earlier).

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹137.12
Market cap
₹2,292 cr
P/E
34.7
P/B
—
ROE
3.1%
ROCE
1.6%
Debt / equity
0
Dividend yield
1.09%
1-year return
-26.2%
52-week high
₹211.2
52-week low
₹125.31
Operating margin
4.4%

Growth

Revenue (last 12 months)₹1,370 cr
Net profit (last 12 months)₹66 cr
Sales growth, 3 years (yearly)-7.4%
Profit growth, 3 years (yearly)-28.0%

At a glance

Ownership
Weak

Promoters 33.8% (unchanged in a year), pledged 22.9%, institutions 12.2%.

Valuation
Moderate

P/E 34.7, dividend yield 1.1%. Price relative to earnings and book value (low is cheaper, not better).

Efficiency
Weak

ROE 3.1%, ROCE 1.6%, operating margin 4.4%: how much profit it earns on the money it uses.

Financials
Weak

Debt/equity 0.00, Profit growth -28.0% and sales growth -7.4% a year over 3 years.

Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.

Strengths and limitations

Strengths
  • Virtually debt-free (debt/equity 0.1 or less).
Limitations
  • Low return on equity (3.1%).
  • Thin operating margin (4.4%).
  • Profit fell 28.0% a year over 3 years.
  • Promoters have pledged 22.9% of their shares.

Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.

Latest results in brief (Q2 FY27)

NOCIL Q2 FY27 results (consolidated figures, as filed on NSE).

Revenue was ₹426.89 crore, up 33.2% YoY and up 5.9% QoQ.

Net profit was ₹24.05 crore, up 98.4% YoY and down 13.4% QoQ.

Operating margin was 8.4% (7% a year ago).

EPS was ₹1.44, up 97.3% YoY and down 13.3% QoQ.

NOCIL के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।

राजस्व: ₹426.89 करोड़; पिछले साल की तुलना में 33.2% की बढ़त, पिछली तिमाही की तुलना में 5.9% की बढ़त।

शुद्ध मुनाफ़ा: ₹24.05 करोड़; पिछले साल की तुलना में 98.4% की बढ़त, पिछली तिमाही की तुलना में 13.4% की गिरावट।

ऑपरेटिंग मार्जिन: 8.4% (एक साल पहले 7%)।

EPS: ₹1.44; पिछले साल की तुलना में 97.3% की बढ़त, पिछली तिमाही की तुलना में 13.3% की गिरावट।

NOCILના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).

આવક (રેવન્યુ): ₹426.89 કરોડ; ગયા વર્ષની સરખામણીએ 33.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 5.9% વધારો.

ચોખ્ખો નફો: ₹24.05 કરોડ; ગયા વર્ષની સરખામણીએ 98.4% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 13.4% ઘટાડો.

ઓપરેટિંગ માર્જિન: 8.4% (એક વર્ષ પહેલાં 7%).

EPS: ₹1.44; ગયા વર્ષની સરખામણીએ 97.3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 13.3% ઘટાડો.

Written from the filed numbers. Not a recommendation.

Smart-money activity

19/100 · Weak over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-10-29: Q2 FY27 results: profit +98.4% YoY2026-08-03: Q1 FY27 results: profit +60.8% YoY2026-07-24: Dividend ₹1.5 (ex-date)2026-05-07: Q4 FY26 results: profit −18.2% YoY2026-02-11: Q3 FY26 results: profit −28.3% YoY

● Results   ● Dividend

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Quarterly results (consolidated)

QuarterRevenueNet profitProfit YoYOp. marginEPS ₹
Sept 2026₹427 cr₹24 cr+98.4%8.4%1.44
Jun 2026₹403 cr₹28 cr+60.8%11.2%1.66
Mar 2026₹330 cr₹17 cr-18.2%6.4%1.02
Dec 2025₹316 cr₹9 cr-28.3%8.5%0.55

Shareholding trend

HolderSept 2026Jun 2026Mar 2026Dec 2025
Promoters33.76%33.76%33.76%33.76%
Foreign institutions (FII)5.28%4.78%4.55%4.47%
Domestic institutions (DII)6.96%7.47%7.91%6.49%
Mutual funds6.03%6.69%7.13%5.68%
Retail investors25.58%25.66%26.20%26.45%
Number of shareholders1,56,0301,61,3421,65,8351,62,167

Common questions

What was NOCIL Limited's latest quarterly profit?

NOCIL Limited reported a net profit of ₹24 cr for the quarter ended Sept 2026 (+98.4% on the same quarter a year earlier), on revenue of ₹427 cr.

How much do promoters hold in NOCIL Limited?

Promoters held 33.76% of NOCIL Limited at the end of Sept 2026, with 22.86% of promoter shares pledged.

Is NOCIL Limited debt-free?

Its latest reported debt-to-equity ratio is 0, so it carries little or no borrowing on the balance sheet.

What is NOCIL Limited's P/E ratio?

About 34.7, based on the last 12 months' earnings and a price of ₹137.12 (data 2026-11-01).

What is the 52-week high and low of NOCIL Limited?

The 52-week high is ₹211.2 and the 52-week low is ₹125.31.

Compared with similar companies

CompanyPriceMarket capP/EP/BROEROCEDebt/eq.1-yr return
NOCIL Limited₹137.12₹2,292 cr34.7—3.1%1.6%0-26.2%
Apcotex Industries Ltd₹476.75₹2,485 cr15.3—17.3%18.3%0.16+34.2%
India Glycols Limited₹331.7₹2,219 cr6.8—11.3%12%0.58+64.5%
Rossari Biotech Ltd₹399.25₹2,212 cr14.51.611.8%13.6%0.33-38.2%
JG Chemicals Limited₹562.4₹2,205 cr29.3—13.3%14%0.01+28.2%
Shree Pushkar Chemicals & Fertilisers Ltd.₹602.6₹1,942 cr27.4—12.2%12.9%0.22+41.3%

Compare NOCIL with APCOTEXIND in detail →

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open NOCIL in NSE Scanner →
Share on WhatsAppShare on Telegram